Alpha Teknova Inc. (TKNO)
6.37
0.51 (8.70%)
At close: Mar 24, 2025, 3:59 PM
6.50
2.04%
After-hours: Mar 24, 2025, 05:05 PM EDT
8.70% (1D)
| Bid | 6.2 |
| Market Cap | 340.39M |
| Revenue (ttm) | 44.2M |
| Net Income (ttm) | -31.32M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -11.18 |
| Forward PE | -24.53 |
| Analyst | Buy |
| Ask | 6.49 |
| Volume | 466,559 |
| Avg. Volume (20D) | 354,870 |
| Open | 6.01 |
| Previous Close | 5.86 |
| Day's Range | 5.99 - 6.43 |
| 52-Week Range | 1.16 - 10.37 |
| Beta | 0.42 |
About TKNO
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sa...
Sector Healthcare
IPO Date Jun 25, 2021
Employees 173
Stock Exchange NASDAQ
Ticker Symbol TKNO
Website https://www.teknova.com
Analyst Forecast
According to 1 analyst ratings, the average rating for TKNO stock is "Buy." The 12-month stock price forecast is $5, which is a decrease of -21.51% from the latest price.
Stock ForecastsNext Earnings Release
Alpha Teknova Inc. is scheduled to release its earnings on May 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+3.92%
Alpha Teknova shares are trading higher after the ...
Unlock content with
Pro Subscription
